Fusion Pharmaceuticals Inc.

5 enregistrements totalisant 1,657,843.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.

Intégrer ce graphique

Par ministère

Conseil national de recherches Canada $1,657,843 5 enregistrements

Enregistrements

Fusion Pharmaceuticals Inc. $999,900.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2020-2021
Canada

This project is focused on the discovery and pre-clinical development of targeted alpha therapeutics using camelid-based constructs for the treatment of solid tumors with high unmet medical need.

Fusion Pharmaceuticals Inc. $255,696.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
EF 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

Fusion Pharmaceuticals Inc. $213,444.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
EF 2020-2021
Canada

The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.

Fusion Pharmaceuticals Inc. $113,803.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
EF 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

Fusion Pharmaceuticals Inc. $75,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2018-2019
Canada

Fusion Pharmaceuticals, Inc. is a new Canadian pharmaceutical company that develops innovative targeted radiotherapy drugs. The project is focused on studying the synergistic effects of Fusion’s targe...